Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$0.24
-3.1%
$0.22
$0.12
$3.67
$11.36M0.07887,604 shs547,094 shs
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
$1.18
+8.8%
$0.67
$0.40
$1.49
$14.83M2.24551,131 shs2.23 million shs
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$9.02
-3.2%
$9.50
$3.81
$37.50
$11.99M0.24192,469 shs43,492 shs
Venus Concept Inc. stock logo
VERO
Venus Concept
$2.62
-11.4%
$2.41
$2.10
$14.50
$3.71M0.07693,001 shs241,125 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.00%-4.38%+9.44%+33.33%-92.06%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
0.00%+38.24%+61.85%+96.55%-13.60%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
0.00%-1.04%-62.87%+61.13%-33.71%
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00%+19.95%-17.77%+6.30%-62.37%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.671 of 5 stars
0.05.00.00.00.61.70.0
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
2.8432 of 5 stars
3.55.00.00.01.81.70.0
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
2.0672 of 5 stars
3.22.00.00.01.91.70.6
Venus Concept Inc. stock logo
VERO
Venus Concept
1.1488 of 5 stars
0.02.00.00.02.53.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.00
N/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
3.00
Buy$2.0070.21% Upside
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
2.33
Hold$100.001,009.26% Upside
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest VERO, LYRA, DHAI, and IINN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/2/2025
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/2/2025
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$2.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$64.47M0.18N/AN/A($0.80) per share-0.30
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/A$0.34 per shareN/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$1.53M7.84N/AN/A$8.86 per share1.02
Venus Concept Inc. stock logo
VERO
Venus Concept
$64.83M0.06N/AN/A$4.30 per share0.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
-$8.44M-$0.30N/AN/A-13.59%N/A-25.97%N/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-$11.05MN/A0.00N/AN/AN/AN/AN/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/13/2025 (Estimated)
Venus Concept Inc. stock logo
VERO
Venus Concept
-$47M-$76.30N/AN/A-81.26%-752.29%-54.52%8/12/2025 (Estimated)

Latest VERO, LYRA, DHAI, and IINN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Venus Concept Inc. stock logo
VERO
Venus Concept
-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 million
5/6/2025Q1 2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/AN/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A
0.51
0.34
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
0.09
2.02
1.89
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/A
2.96
2.96
Venus Concept Inc. stock logo
VERO
Venus Concept
7.91
1.28
0.79

Institutional Ownership

CompanyInstitutional Ownership
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
27.76%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
12.72%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
95.62%
Venus Concept Inc. stock logo
VERO
Venus Concept
87.41%

Insider Ownership

CompanyInsider Ownership
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
49.58%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
29.40%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
3.25%
Venus Concept Inc. stock logo
VERO
Venus Concept
28.04%
CompanyEmployeesShares OutstandingFree FloatOptionable
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A47.34 million23.87 millionN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
2012.62 million8.91 millionNot Optionable
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
501.33 million1.28 millionOptionable
Venus Concept Inc. stock logo
VERO
Venus Concept
4101.42 million1.03 millionNot Optionable

Recent News About These Companies

Venus Concept Inc News (VERO) - Investing.com
Venus Concept Shares Soar on Sale of Hair Business

New MarketBeat Followers Over Time

Media Sentiment Over Time

DIH Holding US stock logo

DIH Holding US NASDAQ:DHAI

$0.24 -0.01 (-3.11%)
Closing price 07/3/2025 03:49 PM Eastern
Extended Trading
$0.24 0.00 (-1.67%)
As of 04:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

Inspira Technologies OXY B.H.N. stock logo

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$1.18 +0.10 (+8.80%)
Closing price 07/3/2025 03:53 PM Eastern
Extended Trading
$1.18 0.00 (0.00%)
As of 05:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Lyra Therapeutics stock logo

Lyra Therapeutics NASDAQ:LYRA

$9.02 -0.30 (-3.17%)
Closing price 07/3/2025 03:45 PM Eastern
Extended Trading
$9.11 +0.09 (+1.01%)
As of 04:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Venus Concept stock logo

Venus Concept NASDAQ:VERO

$2.62 -0.34 (-11.36%)
Closing price 07/3/2025 03:51 PM Eastern
Extended Trading
$2.44 -0.17 (-6.65%)
As of 04:40 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.